MIPS medicinal chemistry platform progresses partnered research programs via the Therapeutic Innovation Australia pipeline initiative
The Australian Translational Medicinal Chemistry Facility (ATMCF) and partners have received over $500,000 in funding for five different projects as part of the
Leading drug developers publish insights in three prestigious international journals.
A team of international researchers including experts from Certara, the
A team of international researchers including Monash University academics has discovered that, contrary to previous belief, fructose causes liver toxicity by changing the barrier function of the intestine.
The Monash Faculty of Pharmacy and Pharmaceutical Sciences has launched a new website aimed at capturing the wide variety of contributions that
Monash University to accelerate the development of novel medicine designed to save women’s lives in child birth in collaboration with Janssen
Postpartum haemorrhage (PPH), a condition of excessive blood loss after birth, is the world’s leading cause of maternal mortality, resulting in an estimated 60,000 deaths per year in resource-limited countries. A novel form of oxytocin, an
Researchers from Monash University’s Institute of Pharmaceutical Sciences (MIPS) together with other Monash and international collaborators have discovered a new target for drugs that could potentially prevent heart attacks and strokes by
Monash University researchers have been featured in Australian media outlets as the global race to produce a vaccine against COVID-19 speeds up.
Nutrition breakthrough: Australian scientists mimic the behaviour of cow and human milk fats during digestion
In an important step forward for infant milk substitutes and nutrition, researchers from Monash University’s Institute of Pharmaceutical Sciences (MIPS) have shown that simple fat mixtures can imitate the behaviour of vastly more complex
Researchers from Monash University’s Institute of Pharmaceutical Sciences (MIPS) have discovered that ozonide antimalarials – a new class of antimalarial drugs - initially target the precarious ‘haemoglobin digestion